FIELD: medicinal products.
SUBSTANCE: application describes enteric coated soft gelatine capsules containing a filling material and an enteric coated shell composition, characterized by the following: the enteric characteristics of the capsules can be achieved without applying an enteric coating or the addition of conventional enteric polymers.
EFFECT: obtaining enteric coated soft gelatine capsules.
17 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ENTERIC CAPSULES OF SOFT GELATIN | 2019 |
|
RU2789789C2 |
| SUSTAINED RELEASE SOFT GELATINE CAPSULES | 2020 |
|
RU2822392C2 |
| DOSAGE FORMS OF RISEDRONATE | 2005 |
|
RU2381791C2 |
| PHARMACEUTICAL SOFT GELATIN CAPSULE DOSAGE FORM WITH MODIFIED GUAR GUM | 2014 |
|
RU2676480C2 |
| SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | 1992 |
|
RU2120798C1 |
| COMPOSITION CONTAINING PHENOFIBRIN ACID, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE | 2003 |
|
RU2356549C2 |
| MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES | 2005 |
|
RU2359678C2 |
| CAPSULES CONTAINING WATER FILLING COMPOSITIONS, STABILISED WITH DERIVATIVE OF CYCLODEXTRIN | 2003 |
|
RU2359698C2 |
| FAST DISPERSING GELATIN-COATED TABLETS | 2005 |
|
RU2367413C2 |
| CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS UNSTABLE IN MEDICINAL ACID MEDIUM | 2006 |
|
RU2440101C2 |
